CheckMyRecalls

Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8…

Viatris Inc recalls Cardura XL (doxazosin) extended release tablets 8 mg and 1 more

Published
22 Jan 2025
Units affected
2 products
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-079-93

Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, Distributed by Viatris Specialty LLC, Morgantown, WV 26505, NDC 58151-078-93

Brand / company
Viatris Inc
Codes / lots
Lot # 8181625, Exp 12/31/2025 | Lot# 8182298, Exp 10/31/2025
Distribution
USA nationwide.
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 22 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.